Our firm is about people. That is our motto and that will always be our reality.
We do our best to get to know our clients, understand their situations, and get them the compensation they deserve.
At TorHoerman Law, we believe that if we continue to focus on the people that we represent, and continue to be true to the people that we are – justice will always be served.
Without our team, we would’nt be able to provide our clients with anything close to the level of service they receive when they work with us.
The TorHoerman Law Team commits to the sincere belief that those injured by the misconduct of others, especially large corporate profit mongers, deserve justice for their injuries.
Our team is what has made TorHoerman Law a very special place since 2009.
The Bard PowerPort Implantable Port Device is a medical device used to deliver medications into the bloodstream.
The Bard port catheter has been linked to serious complications and injuries, including migration, infection, thrombosis, and more.
Our lawyers are actively accepting claims from people who allege serious injuries and complications from these medical devices.
Question: What injuries are linked to the Bard PowerPort Implantable Port Device?
Answer: The Bard PowerPort implantable port device has been linked to several serious injuries.
These injuries include, but are not limited to catheter fractures, catheter migration, deep vein thrombosis (DVT), damage to veins and blood vessels, catheter infection, blood vessels necrosis, blood clots, and arterial puncture.
On this page, we’ll discuss this question in further depth, an overview of what the Bard PowerPort implantable port device is, the risks and complications associated with it, and much more.
In recent years, concerns have arisen regarding the safety of the Bard PowerPort implantable port device.
Patients who have undergone implantation of this medical device have reported various complications and injuries associated with its use.
Injuries linked to the defective Bard Power Port catheter device include catheter failure, fracture, migration, blood clots, deep vein thrombosis, and more.
Injured patients are filing lawsuits against the medical device company.
Bard PowerPort Lawsuits claim that the use of this implantable catheter port device results in an increased risk for severe injuries.
If you or a loved one has suffered from any of these complications after receiving a Bard PowerPort implantable port, you may be eligible to file a Bard PowerPort Lawsuit.
Contact TorHoerman Law today for a free consultation.
You can also use the chatbot on this page to find out if you qualify for the Bard PowerPort lawsuit instantly.
Our Bard PowerPort lawyers have decades of experience securing compensation for people filing product liability lawsuits.
We understand the impacts that these injuries can have on a patient’s quality of life, and we are committed to representing individuals harmed at no fault of their own.
If your PowerPort fractured or otherwise injured you, reach out to our PowerPort lawyers today.
Bard PowerPort devices, designed to facilitate the administration of medications, fluids, and blood products, have been associated with several serious injuries and complications.
Patients with Bard PowerPort can maintain a more normal quality of life, as the device is implanted subcutaneously and is less noticeable than external catheters.
The port protects smaller peripheral veins from irritation caused by harsh medications by delivering them into larger central veins.
Regular flushing of the port with saline or heparin is required to prevent blockages.
Complications from the Bard PowerPort can include pinch-off syndrome, which occurs when the catheter is pinched between the clavicle and rib, blocking the tubing and requiring surgical intervention.
Patients with Bard PowerPorts have reported serious injuries including punctures to sensitive organs, cardiac issues, and even death due to device failures.
Complications, injuries, and adverse health effects linked to the defective port catheters include:
Catheter migration is a significant concern associated with the Bard PowerPort catheters.
Catheter migration occurs when the catheter tube, a thin tube that connects the port to a larger vein, shifts from its intended position.
When catheter migration happens, it can lead to several complications, including:
Catheter fracture is another severe issue associated with the Bard PowerPort device.
This situation occurs when the catheter, which is typically made of flexible material, breaks or snaps.
The consequences of catheter fracture include:
Deep vein thrombosis (DVT) is a severe condition where blood clots form within deep veins, usually in the legs.
In the context of the Bard PowerPort device, thrombosis can occur around the catheter or in the blood vessels connected to the port.
Complications associated with thrombosis include:
Infections related to the defective Bard PowerPort device are a significant concern.
Cracks, fissures, and fractures on the port catheter device can increase the risk for infection.
Infections can lead to a range of health issues, including:
In addition to the injuries, patients have reported other complications associated with the Bard PowerPort catheter device.
Additional Bard PowerPort complications and injuries include:
The Bard PowerPort is a medical device designed to simplify the process of administering medications, chemotherapy, and drawing blood for patients who require frequent intravenous (IV) treatments.
The Bard PowerPort is a small implantable port-catheter system that enhances medical care and patient comfort.
The Bard PowerPort device, manufactured by Bard Access Systems, Inc. (a subsidiary of Becton Dickinson and Company), is a type of vascular access device.
It is a small, round, flat implantable port placed beneath the skin, typically in the upper chest area.
The device includes a self-sealing septum and a catheter that connects to a major vein, such as the subclavian or jugular vein.
The primary purpose of the Bard PowerPort device is to provide a reliable and convenient means for healthcare providers to access a patient’s vascular system.
This access is essential for various medical procedures, including:
The Bard PowerPort is primarily useful for patients who require long-term or frequent IV treatments.
Individuals who may use the PowerPort includes, but is not limited to:
While the port catheter devices have been instrumental in improving the quality of care for many patients, there have been reported issues and complications associated with certain models.
The Bard PowerPort’s design and material composition render it particularly brittle, making the tubing and other components prone to breaking under stress.
Several adverse event reports have reached the U.S. Food and Drug Administration (FDA) regarding complications related to the Bard PowerPort medical devices.
Barium sulfate, used in the Bard PowerPort’s catheter material, can produce microfractures within the material, leading to increased risk of breakage and bacterial colonization.
On March 26, 2020, the FDA issued a Class II recall for certain Bard PowerPort devices, which contained the wrong tunneler tips.
This error could affect the placement of the device and lead to severe complications.
Additionally, the FDA Manufacturer and User Facility Device Experience (MAUDE) database contains numerous reports of complications associated with Bard PowerPort devices, including malfunctions and injuries.
On February 18, 2022, the FDA terminated the Bard PowerPort recall, and there are currently no active recalls for these medical devices.
However, patients and healthcare providers should remain aware of potential complications and promptly report any issues to the FDA.
In response to the reported injuries and complications associated with the Bard PowerPort device, multiple plaintiffs filed Bard PowerPort lawsuits against Bard Access Systems, Inc.
Aside from the medical device manufacturer, its parent company, Becton Dickinson and Company, is also a primary defendant in these lawsuits.
The Bard PowerPort Multidistrict Litigation (MDL) was established in August 2023 to streamline the resolution of lawsuits alleging similar claims against Bard Access Systems and its parent company.
The Bard PowerPort Lawsuit allegations focus on three main issues:
Additionally, the Bard PowerPort MDL alleges that the company was aware of design defects in their devices but failed to take appropriate action, putting patients at risk.
Thousands of Bard PowerPort lawsuits have been consolidated into multidistrict litigation (MDL) in the U.S. District Court for the District of Arizona.
Judge David G. Campbell presides over MDL 3081, allowing for a more efficient and streamlined legal process for similar lawsuits.
As the Bard PowerPort lawsuits progress, lawyers estimate that the average Bard PowerPort settlement could range from $10,000 to over $250,000.
However, the final settlement amount will depend on various factors, such as the severity of injuries and individual circumstances.
These estimations for Bard PowerPort settlement amounts are merely projections and are not a guarantee of financial compensation in the Bard PowerPort Lawsuit.
Visit this page for more information on projected Bard PowerPort Lawsuit settlement amounts.
Individuals who have experienced injuries or complications related to the Bard PowerPort device may qualify for legal action if they meet specific criteria.
Potential plaintiffs in Bard PowerPort Lawsuits may include:
It is essential to consult with a qualified Bard PowerPort injury lawyer to determine if you are eligible for legal action and to understand your rights and options.
At TorHoerman Law, our team of experienced Bard PowerPort injury lawyers can evaluate your case and help guide you through the legal process.
We understand the toll that these medical devices can have on individuals and their families, and we are dedicated to fighting for your rights.
If you or a loved one has experienced adverse events, injuries, or other complications associated with the Bard PowerPort device, you may be eligible to file a Bard PowerPort Lawsuit.
Contact TorHoerman Law today for a free consultation.
You can also use the chatbot on this page to find out if you qualify for the Bard PowerPort lawsuit instantly.
Reach out to our Bard PowerPort Lawyers for more information and to ask any questions you may have about the Bard PowerPort device.
The Bard PowerPort is an implantable port-catheter system designed to provide access to a patient’s bloodstream for administering medications and collecting blood samples.
The Bard PowerPort device is commonly used in patients with cancer undergoing chemotherapy, individuals requiring long-term intravenous therapy, or those who need frequent blood draws.
When defective PowerPort devices fail, the result can be serious medical complications that disrupt normal blood flow and interfere with safe treatment.
Plaintiffs in Bard PowerPort lawsuits allege that catheter fracture, migration, thrombosis, infection, and other malfunctions can puncture blood vessels, trigger internal injuries, or otherwise disrupt normal blood flow in ways that require additional procedures or emergency care.
Several Bard PowerPort lawsuits also describe complications such as bloodstream infection, vascular injury, clot formation, and pain during use, all of which have become central to the Bard PowerPort litigation.
Individuals who have experienced injuries or complications related to the Bard PowerPort device and families of deceased patients may qualify for legal action.
It’s advisable to consult with an attorney specializing in medical device litigation to assess eligibility.
No, there is not a Bard PowerPort class action lawsuit.
Bard PowerPort Lawsuits are consolidated into multidistrict litigation (MDL).
MDL is a special federal legal procedure that allows for cases alleging similar injuries and facts to be centralized in a single US District Court.
MDL is different from a class action lawsuit.
In the event of a settlement in an MDL, compensation is distributed to claimants according to the facts and circumstances of their individual lawsuits.
In a class action lawsuit, settlement compensation is divided evenly among all claimants regardless of their individual circumstances.
The latest Bard PowerPort catheter lawsuit updates continue to focus on the growth of the Bard Port Catheter MDL, where thousands of Bard PowerPort lawsuits have been centralized for coordinated pretrial proceedings.
These Bard PowerPort cases involve allegations that the Bard PowerPort family contained defects that caused fracture, migration, thrombosis, infection, and other injuries.
As Bard PowerPort trials move closer, many plaintiffs represented by Bard PowerPort attorneys are watching how discovery, expert rulings, and bellwether scheduling may affect future resolution of Bard PowerPort claims involving medical bills, lost wages, and other damages.
Plaintiffs in Bard PowerPort litigation are generally seeking financial compensation for losses tied to defective PowerPort devices, including medical bills, pain and suffering, lost wages, and the cost of additional medical treatment made necessary by device-related injuries.
Estimates about recovery vary widely, with some discussions placing potential settlement ranges from $10,000 to over $250,000, while other projections suggest that certain severe Bard PowerPort claims could fall between $150,000 and $300,000 or more depending on the type of injury, causation evidence, and long-term harm.
In many Bard port catheter lawsuits, the claimed damages depend heavily on the specific medical complications involved, such as whether fracture or migration caused vascular damage, whether thrombosis impaired blood flow, or whether infection and other complications led to extended hospitalization and ongoing care.
The Bard PowerPort system is an implant port system implanted beneath the skin to provide long term vascular access for patients who need ongoing medical treatment, including chemotherapy, transfusions, and other infusions.
The device includes a port with a self-sealing silicone septum designed for repeated punctures without leaking, along with a catheter that is threaded into a large vein so medical providers can deliver treatment directly into the bloodstream while preserving healthy peripheral veins and maintaining blood flow.
Bard PowerPort users may receive medications, contrast media, platelets, plasma, and other therapies through the
Owner & Attorney - TorHoerman Law
Here, at TorHoerman Law, we’re committed to helping victims get the justice they deserve.
Since 2009, we have successfully collected over $4 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TorHoerman Law, we believe that if we continue to focus on the people that we represent, and continue to be true to the people that we are – justice will always be served.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.
In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.
In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.
In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.
In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
Here, at TorHoerman Law, we’re committed to helping victims get the justice they deserve.
Since 2009, we have successfully collected over $4 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?